Radiation therapy for liver metastases

Current Opinion in Supportive and Palliative Care

Volumn 6, Issue 1, 2012, Pages 97-102

  Romero, Alejandra Mendez ^a   Høyer, Morten ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Liver metastases; Radiation therapy; Stereotactic body radiation therapy; Whole liver radiation therapy

Indexed keywords

HUMAN; INSTRUMENTATION; LIVER TUMOR; METASTASIS; METHODOLOGY; RADIOSURGERY; REVIEW;

HUMANS; LIVER NEOPLASMS; RADIOSURGERY;

EID: 84861802557     PISSN: 17514258     EISSN: 17514266     Source Type: Journal    
DOI: 10.1097/SPC.0b013e32834de6d8     Document Type: Review

References (46)

1. Hess KR, Varadhachary GR, Taylor SH, et al. Metastatic patterns in adenocarcinoma. Cancer 2006; 106:1624-1633.
2. Lo SS, Teh BS, Mayr NA, et al. Stereotactic body radiation therapy for oligometastases. Discov Med 2010; 10:247-254.
3. Simmonds PC, Primrose JN, Colquitt JL, et al. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer 2006; 94:982-999.
4. Wong SL, Mangu PB, Choti MA, et al. American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. J Clin Oncol 2010; 28:493-508.
5. Cunningham D, Atkin W, Lenz HJ, et al. Colorectal cancer. Lancet 2010; 375:1030-1047.
6. Hoyer M, Erichsen R, Gandrup P, et al. Survival in patients with synchronous liver metastases in Central and Northern Denmark, 1998-2009. Clin Epidemiol 2011; 3 (Suppl 1):11-17.
7. House MG, Ito H, Gonen M, et al. Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution. J Am Coll Surg 2010; 210:744-745.
8. Lax I, Blomgren H, Naslund I, Svanstrom R. Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects. Acta Oncol 1994; 33:677-683.
9. Worm ES, Hansen AT, Petersen JB, et al. Inter- and intrafractional localisation errors in cone-beam CT guided stereotactic radiation therapy of tumours in the liver and lung. Acta Oncol 2010; 49:1177-1183.
10. Wunderink W, Mendez Romero A, Seppenwoolde Y, et al. Potentials and limitations of guiding liver stereotactic body radiation therapy set-up on liverimplanted fiducial markers. Int J Radiat Oncol Biol Phys 2010; 77:1573-1583.
11. Lee MT, Kim JJ, Dinniwell R, et al. Phase I study of individualized stereotactic body radiotherapy of liver metastases. J Clin Oncol 2009; 27:1585-1591.
12. Rusthoven KE, Kavanagh BD, Cardenes H, et al. Multiinstitutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 2009; 27:1572-1578.
13. Vautravers-Dewas C, Dewas S, Bonodeau F, et al. Image-guided robotic stereotactic body radiation therapy for liver metastases: is there a dose response relationship? Int J Radiat Oncol Biol Phys 2011; 81:e39-e47.
14. Langen KM, Jones DT. Organ motion and its management. Int J Radiat Oncol Biol Phys 2001; 50:265-278.
15. Keall PJ, Mageras GS, Balter JM, et al. The management of respiratory motion in radiation oncology report of AAPM Task Group 76. Med Phys 2006; 33:3874-3900.
16. Wunderink W, Mendez Romero A, de KW, et al. Reduction of respiratory liver tumor motion by abdominal compression in stereotactic body frame, analyzed by tracking fiducial markers implanted in liver. Int J Radiat Oncol Biol Phys 2008; 71:907-915.
17. Eccles C, Brock KK, Bissonnette JP, et al. Reproducibility of liver position using active breathing coordinator for liver cancer radiotherapy. Int J Radiat Oncol Biol Phys 2006; 64:751-759.
18. Ford EC, Mageras GS, Yorke E, et al. Evaluation of respiratory movement during gated radiotherapy using film and electronic portal imaging. Int J Radiat Oncol Biol Phys 2002; 52:522-531.
19. Lu XQ, Shanmugham LN, Mahadevan A, et al. Organ deformation and dose coverage in robotic respiratory-tracking radiotherapy. Int J Radiat Oncol Biol Phys 2008; 71:281-289.
20. Seppenwoolde Y, Berbeco RI, Nishioka S, et al. Accuracy of tumor motion compensation algorithm from a robotic respiratory tracking system: a simulation study. Med Phys 2007; 34:2774-2784.
21. Mendez Romero A, Verheij J, Dwarkasing RS, et al. Comparison of macroscopic pathology measurements with magnetic resonance imaging and assessment of microscopic pathology extension for colorectal liver metastases. Int J Radiat Oncol Biol Phys 2010. [Epub ahead of print]
22. De Pooter JA, Mendez Romero A, Jansen WP, et al. Computer optimization of noncoplanar beam setups improves stereotactic treatment of liver tumors. Int J Radiat Oncol Biol Phys 2006; 66:913-922.
23. Lee MT, Purdie TG, Eccles CL, et al. Comparison of simple and complex liver intensity modulated radiotherapy. Radiat Oncol 2010; 5:115.
24. Balter JM, Brock KK, Litzenberg DW, et al. Daily targeting of intrahepatic tumors for radiotherapy. Int J Radiat Oncol Biol Phys 2002; 52:266-271.
25. Brock KK, Dawson LA, Sharpe MB, et al. Feasibility of a novel deformable image registration technique to facilitate classification, targeting, and monitoring of tumor and normal tissue. Int J Radiat Oncol Biol Phys 2006; 64:1245-1254.
26. Herfarth KK, Debus J, Lohr F, et al. Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial. J Clin Oncol 2001; 19:164-170.
27. Herfarth KK, Debus J. Stereotactic radiation therapy for liver metastases. Chirurg 2005; 76:564-569.
28. Hoyer M, Roed H, Traberg HA, et al. Phase II study on stereotactic body radiotherapy of colorectal metastases. Acta Oncol 2006; 45:823-830.
29. Katz AW, Carey-Sampson M, Muhs AG, et al. Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases. Int J Radiat Oncol Biol Phys 2007; 67:793-798.
30. Mendez Romero A, Wunderink W, Hussain SM, et al. Stereotactic body radiation therapy for primary and metastatic liver tumors: a single institution phase I-II study. Acta Oncol 2006; 45:831-837.
31. Wulf J, Hadinger U, Oppitz U, et al. Stereotactic radiotherapy of targets in the lung and liver. Strahlenther Onkol 2001; 177:645-655.
32. Wulf J, Guckenberger M, Haedinger U, et al. Stereotactic radiotherapy of primary liver cancer and hepatic metastases. Acta Oncol 2006; 45:838-847.
33. Ambrosino G, Polistina F, Costantin G, et al. Image-guided robotic stereotactic radiosurgery for unresectable liver metastases: preliminary results. Anticancer Res 2009; 29:3381-3384.
34. Kim MS, Kang JK, Cho CK, et al. Three-fraction stereotactic body radiation therapy for isolated liver recurrence from colorectal cancer. Tumori 2009; 95:449-454.
35. Stintzing S, Hoffmann RT, Heinemann V, et al. Frameless single-session robotic radiosurgery of liver metastases in colorectal cancer patients. Eur J Cancer 2010; 46:1026-1032.
36. Goodman KA, Wiegner EA, Maturen KE, et al. Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies. Int J Radiat Oncol Biol Phys 2010; 78:486-493.
37. Rule W, Timmerman R, Tong L, et al. Phase I dose-escalation study of stereotactic body radiotherapy in patients with hepatic metastases. Ann Surg Oncol 2011; 18:1081-1087.
38. Van der Pool AE, Mendez Romero A, Wunderink W, et al. Stereotactic body radiation therapy for colorectal liver metastases. Br J Surg 2010; 97:377-382.
39. Chang DT, Swaminath A, Kozak M, et al. Stereotactic body radiotherapy for colorectal liver metastases: a pooled analysis. Cancer 2011; 117:4060-4069.
40. McCammon R, Schefter TE, Gaspar LE, et al. Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 2009; 73:112-118.
41. Mendez Romero A, Wunderink W, van Os RM, et al. Quality of life after stereotactic body radiation therapy for primary and metastatic liver tumors. Int J Radiat Oncol Biol Phys 2008; 70:1447-1452.
42. Bydder S, Spry NA, Christie DR, et al. A prospective trial of short-fractionation radiotherapy for the palliation of liver metastases. Australas Radiol 2003; 47:284-288.
43. Yeo SG, Kim DY, Kim TH, et al. Whole-liver radiotherapy for end-stage colorectal cancer patients with massive liver metastases and advanced hepatic dysfunction. Radiat Oncol 2010; 5:97.
44. Borgelt BB, Gelber R, Brady LW, et al. The palliation of hepatic metastases: results of the Radiation Therapy Oncology Group pilot study. Int J Radiat Oncol Biol Phys 1981; 7:587-591.
45. SolimanH,WongR, Ringash J, et al. Preliminary results of a phase II study of single fraction palliative radiotherapy for symptomatic hepatocellular carcinoma and liver metastases. Radiother Oncol 2010; 88 (S2):S17-S18.
46. Nordlinger B, Sorbye H, Glimelius B, et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 2008; 371:1007-1016.